Although estimates have been adjusted downward in light of the most recent data, researchers still predict sharp increases in the U.S. incidence and prevalence of end-stage renal disease (ESRD) in the years ahead, according to a paper being presented at the American Society of Nephrology's 40th Annual Meeting and Scientific Exposition in San Francisco.
"The expected number of patients with ESRD in 2020 is almost 785,000, which is an increase of over 60 percent compared to 2005," comments Dr. David T. Gilbertson of the U.S. Renal Data System (USRDS) and the Minneapolis Medical Research Foundation, Minneapolis, Minn. Using data available through 2005, the study updates previous estimates based on data through 2000. The researchers used statistical techniques to project available data on the ESRD population to the year 2020. The model took into account a wide range of factors, including expected trends in population growth and the rising rate of diabetes—the main cause of kidney disease. The study also incorporated the latest data on the risk of progression to ESRD once kidney disease is present.
Based on the results, Dr. Gilbertson and colleagues predict that the U.S. incidence (number of new cases) of ESRD will be about 135,000 in 2015. This figure is about 3,000 lower than the previous estimate. For reasons that are not entirely clear, the incidence of ESRD has been decreasing in recent years, and the updated figure accounts for that trend. The predicted prevalence (total number of cases) of ESRD in 2015 is estimated at 680,000—about 33,000 less than the previous estimate.
Nevertheless, based on a combination of trends—including the aging of the "Baby Boomer" population, rising diabetes rates, and improvements kidney disease treatment allowing better survival—the authors project continued increases in numbers of Americans affected by ESRD.
By 2020, the incidence 1725 I Street NW . Suite 510 . Washington, DC 20006 Tel 202-659-0599 . Fax 202-659-0709 . www.asn-online.org The American Society of Nephrology®, ASN®, Renal Week®, CJASN®, JASN®, and NephSAP® are registered trademarks of the American Society of Nephrology. (new cases) of ESRD is expected to rise to 151,000 per year (compared to 107,000 in 2005). Prevalence (all cases) is expected to increase to 785,000 (compared to 485,000 in 2005). "These projections play an important role in shaping public health policy and health care planning related to the treatment of kidney disease," says Dr. Gilbertson. "Medicare pays for the care for the vast majority of patients with ESRD, with costs approaching $60,000 per year for every patient."
The predictions suggest that, despite recent declines in new cases, policymakers should account for continued increases in the health and economic impact of ESRD in the United States. "While relatively flat ESRD incidence rates may show some progress towards Healthy People 2010 goals of reducing ESRD incidence, it is important to know the expected future counts of patients, as opposed to rates, to inform public health policy and health care planning related to the treatment of kidney disease," Dr. Gilbertson says. "The financial and human resources that will be needed to care for these patients in 2020 will be considerable."
The study abstract, "Projecting the ESRD Population to 2020," (SA-FC046) will be presented as part of a Free Communications session on the topic of “Epidemiology and Consequences of Chronic Kidney Disease” on Saturday, November 3 at 4:00 PM in Room 2009 of the Moscone Center.
The ASN is a not-for-profit organization of 10,500 physicians and scientists dedicated to the study of nephrology and committed to providing a forum for the promulgation of information regarding the latest research and clinical findings on kidney diseases. ASN’s Renal Week 2007, the largest nephrology meeting of its kind, will provide a forum for 11,000 nephrologists, to discuss the latest findings in renal research and engage in educational sessions relating advances in the care of patients with kidney and related disorders from October 31 – November 5 at the Moscone Center in San Francisco, CA.
The American Society of Nephrology®, ASN®, Renal Week®, CJASN®, JASN®, and NephSAP® are registered trademarks of the American Society of Nephrology.
Shari Leventhal | EurekAlert!
New study: How does Europe become a leading player for software and IT services?
03.04.2017 | Fraunhofer-Institut für System- und Innovationsforschung (ISI)
Reusable carbon nanotubes could be the water filter of the future, says RIT study
30.03.2017 | Rochester Institute of Technology
Staphylococcus aureus is a feared pathogen (MRSA, multi-resistant S. aureus) due to frequent resistances against many antibiotics, especially in hospital infections. Researchers at the Paul-Ehrlich-Institut have identified immunological processes that prevent a successful immune response directed against the pathogenic agent. The delivery of bacterial proteins with RNA adjuvant or messenger RNA (mRNA) into immune cells allows the re-direction of the immune response towards an active defense against S. aureus. This could be of significant importance for the development of an effective vaccine. PLOS Pathogens has published these research results online on 25 May 2017.
Staphylococcus aureus (S. aureus) is a bacterium that colonizes by far more than half of the skin and the mucosa of adults, usually without causing infections....
Physicists from the University of Würzburg are capable of generating identical looking single light particles at the push of a button. Two new studies now demonstrate the potential this method holds.
The quantum computer has fuelled the imagination of scientists for decades: It is based on fundamentally different phenomena than a conventional computer....
An international team of physicists has monitored the scattering behaviour of electrons in a non-conducting material in real-time. Their insights could be beneficial for radiotherapy.
We can refer to electrons in non-conducting materials as ‘sluggish’. Typically, they remain fixed in a location, deep inside an atomic composite. It is hence...
Two-dimensional magnetic structures are regarded as a promising material for new types of data storage, since the magnetic properties of individual molecular building blocks can be investigated and modified. For the first time, researchers have now produced a wafer-thin ferrimagnet, in which molecules with different magnetic centers arrange themselves on a gold surface to form a checkerboard pattern. Scientists at the Swiss Nanoscience Institute at the University of Basel and the Paul Scherrer Institute published their findings in the journal Nature Communications.
Ferrimagnets are composed of two centers which are magnetized at different strengths and point in opposing directions. Two-dimensional, quasi-flat ferrimagnets...
An Australian-Chinese research team has created the world's thinnest hologram, paving the way towards the integration of 3D holography into everyday...
24.05.2017 | Event News
23.05.2017 | Event News
22.05.2017 | Event News
26.05.2017 | Life Sciences
26.05.2017 | Life Sciences
26.05.2017 | Physics and Astronomy